Dr. Chengxin Zhou received his PhD in Biomedical Engineering in 2013 from University of Texas Southwestern Medical Center. During his PhD study, he investigated various key biomechanical and biochemical mechanisms of corneal keratocyte migration, proliferation and matrix remodeling with in vivo and in vitro tissue-engineered corneal wound healing models. His PhD work also encompassed cellular biomechanics, live cell force monitoring, biologic imaging, corneal tissue engineering. In 2014, he became a senior research fellow in Boston Keratoprosthesis group in Schepens Eye Research Institute-Massachusetts Eye and Ear. The BKPro lab was found by Dr. Claes H. Dohlman and has became a leading group in corneal prosthesis and ocular chemical burn fields worldwide. His research focuses on keratoprosthesis and ophthalmic drug delivery device R&D, biocompatibility, corneal wound remodeling, and inflammation & retinal degeneration associated with ocular chemical burn. His has published many original research articles in well-recognized journals including IOVS, American Journal of Pathology, Experimental Eye Research. He also presented his works in numerous scientific conferences. He also received Master of Science degree in Biomedical Engineering from Wayne State University, with a concentration on Biomechanics.
Dr. Chengxin Zhou Research Interest are Corneal wound healing, Keratoprosthesis, Ophthalmic drug delivery methods, Ocular Chemical burn, Ocular inflammation.